China Oncology Drugs Market: Opportunity Analysis and Industry Forecast, 2019-2026
The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 ...
Report Code : A04505 | Pages : 135 | Category : Life Sciences
Japan Oncology Drugs Market: Opportunity Analysis and Industry Forecast, 2019–2026
The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
Report Code : A05277 | Pages : 147 | Category : Life Sciences
Pet Cancer Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Cancer in pets can be of many forms such as soft tissue sarcomas and mast cell tumors, which potentially can be cured or restricted from spreading further with ...
Report Code : A10911 | Category : Life Sciences
Oncolytic Virus Immunotherapy Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
The oncolytic virus immunotherapy involves the use of viruses to infect and subsequently eliminate cancerous cells. Cancer cells are known to exhibit impaired antiviral defenses, which make them ...
Report Code : A11451 | Category : Life Sciences
Folliculotropic Mycosis Fungoides Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Folliculotropic mycosis fungoides is a type of cutaneous T-cell lymphoma. This is a rare disease in which white blood cells (WBC) turn into cancerous cell due genetic mutation. ...
Report Code : A13192 | Category : Life Sciences
HER2-Positive Breast Cancer Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Human epidermal growth factor receptor 2 (HER2) is a gene that is linked to breast cancer development. Genes contain the recipes for numerous proteins required by a cell to remain healthy and function normally.
Report Code : A15411 | Category : Life Sciences
Neuroblastoma Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
The global neuroblastoma drugs market was valued at $0.7 billion in 2022, and is projected to reach $1.3 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032.
Report Code : A172697 | Pages : 256 | Category : Life Sciences
